Skip to content

Contact +44 (0) 20 7060 7474 email us

Company Information

The Top 50 Pharmaceutical Manufacturing Companies In Ireland

 

Publication Date September 2005
Publisher Research Facts
Product Type Report
Pages 57
ISBN Number not applicable
Product Code RSF00006

Price

£300.00
approximately: $454 | €335

pdf

Buy Now

print £385 ($583 | €430)

Buy Now

Order above formats by FAX

Order by Fax

Summary

Ireland is a key global location for the pharmaceutical industry. Foreign direct investment for the pharmaceutical sector is forty years old with Squibb (now Bristol-Myers Squibb) being the first pharmaceutical company to locate in Ireland in 1964. Currently thirteen of the top fifteen companies in the world have substantial operations in Ireland. More than 17,000 people are employed directly in the industry.

Ireland is now one of the world's largest exporters of pharmaceuticals with €34 billion of intermediates and finished pharmaceuticals exported in 2002. Six out of ten and twelve out of 25 of the world's top selling drugs are produced in Ireland including Lipitor and Zocor. Products are manufactured for global markets.

Many of the pharmaceutical companies in Ireland have established multiple activities, including

Fermentation e.g. Schering-Plough, Wyeth
API e.g. Merck, Pfizer, Yamanouchi,
Sterile Fill/Finish e.g. Genzyme, Allergan
Formulation e.g. Wyeth, Takeda, Pfizer
Shared Services/ Supply Chain Management e.g. Allergan, Pfizer, Novartis
R&D/ Process Development e.g. Wyeth, GlaxoSmithKline, Bristol- Myers Squibb

The sector has become increasingly integrated in recent years. Early investment in fine chemical plants producing bulk active materials has been followed by investment in finished product pharmaceuticals. Many plants are now engaged in product development for Irish and other plants.

This report comprises full profile information for each company, including:

  • Full Company Contact Information - Addresses, Telephone and Fax numbers, Emails, Websites
  • Key Company Decision Makers - from CEO and Main Board to Key Senior Managers
  • Specialised Fields such as Employment, Company Activities, Turnover, Year Established, Ownership
  • SIC and NAICS Classifications

Report Target Market:

(1) Pharmaceutical Manufacturing Companies - Usage: Competitive/Financial Analysis and Partner/Alliance Identification

(2) Suppliers to Pharmaceutical Manufacturing Companies - Usage: Identification of Top Potential Customers and Key Decision Makers

(3) Pharmaceutical Distributors/Wholesalers/Retailers - Usage: Identification of Suppliers

Report data field structure is as follows:

  • Company Name
  • Mailing Address
  • Street Address
  • Company Telephone
  • Company Fax
  • Email
  • Web Address
  • Employment (Individual site/All sites)
  • Top Executives
  • Company Activities
  • SIC Code(s)
  • NAICS Code(s)
  • Location Status
  • Turnover Euro millions
  • Year Established
  • Ownership

Research Facts' reports help you make informed decisions about the markets and firms that affect your business:

  • Learn more about your target markets and target companies
  • Access up-to-date, comprehensive and well-written research on all 50 major players in a market
  • Identify which companies dominate your major markets

Contents

Please note that due to the nature of this report, no Table of Content is available. Feel free to refer to the sample below for further information.
  • Company:
    • Clonmel Healthcare Ltd.
  • Address:
    • Waterford Road
    • Clonmel
    • Tipperary
  • Telephone:
    • +353-52-77777
  • Fax:
    • +353-52-77799
  • Email:
    • info@clonmel-health.ie
  • Website:
    • www.clonmelhealthcare.com
  • Number of Employees:
    • 250
  • Top Executives:
    • Rory O'Riordan, Chief Executive
    • James Hanlon, Director/Finance
    • Anthony Sheehan, Director of International Business Development
    • Martin E Gallagher, Director of Sales & Marketing
    • Kieran Mulhall, IT Manager
    • Andrew Conlon, Head of Logistics
    • Pat Hayes, Director of Manufacturing
    • David Hughes, Manufacturing Manager
    • Michael Grace, Quality Control Manager
    • Walter Heneghan, Training/Engineering Manager
    • Henrietta Carney, Office Manager
  • Activities:
    • Clonmel Healthcare specialises in the manufacture of tablets, capsules and powders for reconstruction. The company manufactures over 100 products according to its own product licences and to customer's formulations and specifications. They produce a range of generic products that are bioequivalent to their corresponding leading ethical products. Clonmel Healthcare's range of products fall under the following general categories; cardiovascular, gastro-intestinal, genito-urinary, antibiotics and antibacterials, analgesic, respiratory, musculo-skeletal, allergic conditions, central nervous system and over the counter/non prescription.
  • SIC Code(s):
    • 2834
  • NAICS Code(s):
    • 325412
  • Turnover (Euro Million):
    • 54.0
  • Year Established:
    • 1970